Disposition of mitoxantrone in patients.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism; D000880:Anthraquinones / Q000008:administration & dosage / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000378:metabolism; D004341:Drug Evaluation; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D007364:Intercalating Agents / Q000008:administration & dosage / Q000378:metabolism*; D008545:Melanoma / Q000188:drug therapy / Q000378:metabolism; D008942:Mitoxantrone; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution
D000880:Anthraquinones; D000970:Antineoplastic Agents; D007364:Intercalating Agents; D008942:Mitoxantrone